Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Congress Examines Ban on Patenting Human Organisms
Under a bill approved by the House of Representatives, the USPTO would be prohibited from issuing patents on human organisms. The provision would allow the USPTO to refuse to grant any application containing a claim that encompasses “any member of the species Homo sapiens at any stage of development.” The bill would codify existing USPTO rules regarding human organisms, but the ban would not interfere with stem cell research. Patents for cells, tissue and other biological products would not be affected, nor would the bill prevent patents for methods of creating biological products. Opponents of the bill argue that the provision would cripple research into therapeutic cloning and that the bill is unnecessary given the USPTO's policy on denying patents on subject matter encompassing human beings. The bill was approved in the House on Dec. 8, 2003 and awaits a vote in the Senate. See, e.g., www.bio.org.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.